AMAL vs PRA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMAL presents a dichotomy between strong fundamental value and bearish sentiment. The Piotroski F-Score of 4/9 indicates stable financial health, while the current price of $42.31 sits below both the Graham Number ($45.21) and the growth-based Intrinsic Value ($80.65). Despite consistent earnings beats and a low P/E ratio relative to the sector, the stock is facing significant headwinds from heavy insider selling and a strongly bearish technical trend (10/100).
ProAssurance (PRA) presents a conflicting profile characterized by a very weak Piotroski F-Score of 2/9, indicating deteriorating fundamental health, despite a stable balance sheet. While the stock is attractively valued—trading near its Graham Number ($24.18) and below its intrinsic value ($29.20) with a P/B of 0.94—the lack of revenue growth (-4.10%) suggests that recent earnings surges are likely driven by cost management rather than organic expansion. Technical trends are heavily bearish (10/100), and the low ROE (3.99%) further dampens the bullish case provided by the PEG ratio.
Compare Another Pair
Related Comparisons
AMAL vs PRA: Head-to-Head Comparison
This page compares Amalgamated Financial Corp. (AMAL) and ProAssurance Corporation (PRA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.